New US label for bevacizumab warns of possible risk of infertility (NeLM News Service, 6 October 2011)

07 Oct 2011


Data from a phase III study suggest that bevacizumab, a breast cancer drug, increases the risk of ovarian failure in premenopausal women.

Full article


Related Topics

Reproduction

Share this story